Literature DB >> 26772615

Down regulation of miR-18a, miR-21 and miR-221 genes in gastric cancer cell line by chrysin-loaded PLGA-PEG nanoparticles.

Farideh Mohammadian1,2,3, Yones Pilehvar-Soltanahmadi1, Mohsen Mofarrah1, Mehdi Dastani-Habashi1, Nosratollah Zarghami1,2.   

Abstract

Chrysin were well-documented as having significant biological roles particularly cancer chemo-preventive activity. However, the poor water solubility of chrysin limited their bioavailability and biomedical applications. In this study, we encapsulate the chrysin into PLGA-PEG nanoparticles for local treatment. In regard to the amount of the drug load, IC50 was significant decreased in nanocapsulated chrysin in comparison with free chrysin. This was confirmed through decrease of miR-18a, miR-21, and miR-221 genes expression by real-time PCR. The results demonstrated that PLGA-PEG-chrysin complexes can be more effective than free chrysin. Therefore, PLGA-PEG can be a better nanocarrier for this kind of hydrophobic flavonoid.

Entities:  

Keywords:  Chrysin; PLGA-PEG; miRNAs; real-time PCR

Mesh:

Substances:

Year:  2016        PMID: 26772615     DOI: 10.3109/21691401.2015.1129615

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  18 in total

1.  Role of miR-18a and miR-25 disruption and its mechanistic pattern in progression of liver cancer.

Authors:  Yijie Lu; Zhai Min; Ancheng Qin; Jianwu Wu; Xinwei Jiang; Zhiming Qiao
Journal:  3 Biotech       Date:  2020-01-28       Impact factor: 2.406

Review 2.  Molecular targeted treatment and drug delivery system for gastric cancer.

Authors:  Lanxin Jiang; Xiaomin Gong; Wangdi Liao; Nonghua Lv; Runwei Yan
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-07       Impact factor: 4.553

3.  Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer.

Authors:  Arman Shahabi; Behrooz Naghili; Khalil Ansarin; Maryam Montazeri; Mehdi Dadashpour; Nosratollah Zarghami
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

4.  Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells

Authors:  Zahra Javan Maasomi; Younes Pilehvar Soltanahmadi; Mehdi Dadashpour; Shahriar Alipour; Somayeh Abolhasani; Nosratollah Zarghami
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01

Review 5.  Research Progress in microRNA-Based Therapy for Gastric Cancer.

Authors:  Xu Zhao; Gao-Feng Hu; Yan-Fen Shi; Wei Xu
Journal:  Onco Targets Ther       Date:  2019-12-24       Impact factor: 4.147

Review 6.  Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer.

Authors:  Xinju Zhang; Yanli Li; Pengfei Qi; Zhongliang Ma
Journal:  Int J Med Sci       Date:  2018-09-07       Impact factor: 3.738

7.  Synergistic Growth Inhibitory Effects of Chrysin and Metformin Combination on Breast Cancer Cells through hTERT and Cyclin D1 Suppression

Authors:  Sara Rasouli; Nosratollah Zarghami
Journal:  Asian Pac J Cancer Prev       Date:  2018-04-25

8.  In-vitro Transcribed mRNA Delivery Using PLGA/PEI Nanoparticles into Human Monocyte-derived Dendritic Cells.

Authors:  Zarin Sharifnia; Mojgan Bandehpour; Hamed Hamishehkar; Nariman Mosaffa; Bahram Kazemi; Nosratollah Zarghami
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

Review 9.  Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives.

Authors:  Ebrahim Rahmani Moghadam; Hui Li Ang; Sholeh Etehad Asnaf; Amirhossein Zabolian; Hossein Saleki; Mohammad Yavari; Hossein Esmaeili; Ali Zarrabi; Milad Ashrafizadeh; Alan Prem Kumar
Journal:  Biomolecules       Date:  2020-09-27

Review 10.  The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection.

Authors:  Jiulue Hu; Jelena Stojanović; Saman Yasamineh; Pooneh Yasamineh; Sathish Kumar Karuppannan; Mohammed Junaid Hussain Dowlath; Hamed Serati-Nouri
Journal:  Arch Virol       Date:  2021-07-19       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.